|
2024
|
G/S
|
Diagnostic preparations for medical use, namely, diagnostic preparations for identifying and dete... |
|
|
G/S
|
Diagnostic preparations, in particular diagnostic preparations for identifying and detecting grow... |
|
2023
|
G/S
|
Pharmaceuticals, medical and veterinary preparations; Sanitary preparations for medical purposes;... |
|
2021
|
Invention
|
Use of macimorelin in assessing growth hormone deficiency in children. The present invention prov... |
|
2020
|
G/S
|
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations adminis... |
|
|
Invention
|
A screening method for diagnosing growth hormone deficiency in pediatric patients by using macimo... |
|
2018
|
Invention
|
Method of assessing growth hormone deficiency in humans by a macimorelin containing composition. ... |
|
2016
|
Invention
|
Enzymatic process for the regioselective manufacturing of n-fmoc-doxorubicin-14-o-dicarboxylic ac... |
|
2014
|
Invention
|
Application of initial doses of lhrh analogues and maintenance doses of lhrh antagonists for the ... |
|
|
G/S
|
Diagnostic preparations, in particular diagnostic
preparations for identifying and detecting gro... |
|
|
G/S
|
Diagnostic preparations, namely diagnostic preparations for identifying and detecting growth horm... |
|
2012
|
Invention
|
Modulating signal transduction pathways with 1-ethyl-3-[3-(1-methyl-1h-pyrazol-4-yl)-pyrido[2.3-b... |
|
|
Invention
|
Pyridopyrazine derivatives, process of manufacturing and uses thereof. 1-ethyl-3-[3-(1-methyl-1H-... |
|
|
Invention
|
Modulating signal transduction pathways with substituted pyridol [2,3-b] pyrazines. Method of mod... |
|
|
Invention
|
Pyridopyrazine derivatives and their use. The present invention provides new pyridopyrazine compo... |
|
|
Invention
|
Pyridopyrazines as highly selective ras-raf-mek-erk signal transduction pathway inhibitors. The i... |
|
|
Invention
|
Non-pathogenic and/or attenuated bacteria capable of inducing apoptosis in macrophages, process o... |
|
2011
|
Invention
|
Prohibitin as target for cancer therapy. The present invention relates to pharmaceutical composit... |
|
|
Invention
|
Triazole derivatives with improved receptor activity and bioavailability properties as ghrelin an... |
|
|
Invention
|
Novel triazole derivatives with improved receptor activity and bioavailability properties as ghre... |
|
|
Invention
|
Perifosine and capecitabine as a combined treatment for cancer. Treatment regimens comprising co-... |
|
2010
|
Invention
|
Naphthyridine derivatives and the use thereof as kinase inhibitors. The present invention relates... |
|
|
Invention
|
Novel naphthyridine derivatives and the use thereof as kinase inhibitors. The present invention r... |
|
|
Invention
|
Use of alkylphosphocholines in combination with antimetabolites for the treatment of benign and m... |
|
|
Invention
|
Use of perifosine in combination with antimetabolites for the treatment of benign and malignant o... |
|
|
Invention
|
Quinoxaline derivatives and their use for treating benign and malignant tumour disorders. The inv... |
|
|
Invention
|
Quinoxaline derivatives and their use for treating benign and malignant tumour disorders. T... |
|
|
Invention
|
Conjugates of disorazoles and their derivatives with cell-binding molecules, novel disorazole der... |
|
2009
|
Invention
|
Use of disorazoles and their derivatives for the treatment of benign and malignant oncoses.
The ... |
|
|
Invention
|
Novel 1,2,4-triazole derivatives and process of manufacturing thereof.
The invention provides 1,... |
|
|
Invention
|
Novel 1,2,4-triazole derivatives and process of manufacturing thereof. The invention discloses a ... |
|
|
Invention
|
Novel 1,2,4-triazole derivatives and process of manufacturing thereof. The invention disclo... |
|
|
Invention
|
Use of lhrh antagonists at non-castrating doses. The invention relates to medicaments compr... |
|
|
Invention
|
Use of lhrh antagonists at non-castrating doses. The invention relates to medicaments comprising ... |
|
|
Invention
|
Recombinant bacteria with e. coli hemolysin secretion system and increased expression and/or secr... |
|
2008
|
Invention
|
Substituted pyrido[2,3-b]pyrazine compounds as modulators of tyrosine kinases. The invention rela... |
|
|
Invention
|
Lhrh antagonists for the treatment of lower urinary tract symptoms.
The present invention provid... |
|
2007
|
Invention
|
Methods and kits to diagnose growth hormone deficiency by oral administration of ep 1572 or ep 15... |
